Fig. 5

Presentation of the prognostic model in the validation set (GSE41613). (A) Distribution of risk scores for each sample in GSE41613. (B) The survival status of each sample in GSE41613. (C) Heatmap displaying gene expression levels in groups with high- and low-risk scores. (D) Survival curves for groups with high- and low-risk scores. (E) Time-dependent ROC curve. (F) Calibration Curve. TCGA, The Cancer Genome Atlas; HNSC, head and neck squamous cell carcinoma; ROC, receiver operating characteristic